Medtronic Recalls Thoracic Stent Graft After Reported Patient Death In Trial


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


  • Medtronic Plc (NYSE: MDT) has announced a voluntary global recall of its Valiant Navion thoracic stent graft system after a patient death was reported in a clinical trial. The company has informed physicians to cease use until further notice.
  • In addition to the single fatality, three patients in the Valiant Evo Global Clinical Trial were observed to have stent fractures, two of which were Type IIIb endoleaks, an uncommon but severe complication of endovascular aortic aneurysm repair.
  • Further analysis of the images, seven out of 87 patients were observed to have stent ring enlargement beyond the design specification.
  • In October 2018, the FDA had approved Medtronic's Valiant Navion system for the minimally invasive repair of all lesions of the descending thoracic aorta, including thoracic aortic aneurysms. 
  • The Valiant Evo prospective, nonrandomized, single-arm trial seeks to demonstrate the safety and efficacy of the stent-graft system in patients with a descending thoracic aortic aneurysm who are candidates for endovascular repair.
  • Price Action: MDT stock is down 1.42% at $117.99 in market trading hours on last check Wednesday.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsHealth CareFDAGeneralsafety recall